August 23, 2023
The Ninth Circuit on Wednesday agreed to review a grant of class certification in a suit by third-party payors alleging that Takeda Pharmaceutical Co. and Eli Lilly & Co. hid risks associated with their anti-diabetes drug Actos.
June 06, 2023
A California federal judge has certified a class of at least hundreds of third-party payors who ponied up money for anti-diabetes drug Actos as part of a suit accusing Takeda Pharmaceutical Co. and Eli Lilly & Co. of hiding the risks associated with the treatment.